methylphenidate hydrochloride cd methylphenidate hydrochloride capsule extended release
1 INDICATIONS AND USAGE Methylphenidate hydrochloride extended-release capsules (CD) are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 15 years of age. Methylphenidate hydrochloride extended-release capsules (CD ) are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 15 years of age
teva pharmaceuticals usa, inc.
CAPSULE WHITE 93 5295
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING How Supplied
METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (CD) are available in six strengths (see Table 4): Table 4: Strengths, Identifying Characteristics, and Packaging Configurations of
METHYLPHENIDATE HYDROCHLORIDE Extended-Release capsules (CD) Strength capsule Color Imprinting on capsule Cap and Body capsules per Bottle NDC Number 10 mg light green opaque cap /white opaque body “93” over “5295” 100 NDC 0093-5295-01 20 mg light turquoise blue opaque cap/white opaque body “93” over “5296” 100 NDC 0093-5296-01 30 mg light brown opaque cap /white opaque body “93” over “5297” 100 NDC 0093-5297-01 40 mg light brown opaque cap/white opaque body “93” over “5298” 100 NDC 0093-5298-01 50 mg light blue opaque cap/white opaque body “93” over “5292” 100 NDC 0093-5292-01 60 mg white opaque cap/white opaque body “93” over “5293” 100 NDC 0093-5293-01 Storage and Handling Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). Keep this and all medications out of the reach of children.
More pills like CAPSULE 93 5295